ClinicalTrials.Veeva

Menu

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. (MELA_2025)

E

Ente Ospedaliero Ospedali Galliera

Status

Enrolling

Conditions

Melanoma of Skin

Study type

Observational

Funder types

Other

Identifiers

NCT06994208
Melanoma_2025

Details and patient eligibility

About

The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.

Secondary objectives are the following:

  • To identify risk factors associated with melanoma in young people.
  • To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years.
  • To analyse the relationship between the clinical and histopathological features of melanoma in young people.
  • To identify the mutational status of B-RAF in the sample of patients analysed.

Enrollment

25 estimated patients

Sex

All

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. written informed consent
  2. age > 18 years and < 40 years
  3. diagnosis of cutaneous melanoma even non-primary

Exclusion criteria

-

Trial design

25 participants in 1 patient group

ARM 1
Description:
Patients with melanoma diagnosis aged between 18 and 39 years.

Trial contacts and locations

1

Loading...

Central trial contact

Sanja Javor, MD; Davide Corradengo

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems